| ALLR |
Allarity Therapeutics, Inc. |
62%
|
Reciprocal relationship from ALLR graph: Reciprocal relationship from ALUR graph: part of these condensed consolidated financial statements. 6 1. Organization and Basis of Presentation Organization A… |
| ALLURION-TECHNOLOGIES-HOLDINGS-INC |
ALLURION-TECHNOLOGIES-HOLDINGS-INC |
62%
|
part of these condensed consolidated financial statements. 6 1. Organization and Basis of Presentation Organization Allurion Technologies, Inc. (“Allurion” or the “Company”) is a vertically integrate… |
| COMPANY-ALLURION-OPCO-ALLURION-AUSTRALIA-PTY-LTD |
COMPANY-ALLURION-OPCO-ALLURION-AUSTRALIA-PTY-LTD |
62%
|
Omnibus Amendment (the "RIFA Amendment") by and among the Company, Allurion Opco, Allurion Australia Pty Ltd, a proprietary limited company organized under the laws of Australia and a wholly-owned su… |
| COMPUTE-HEALTH-ACQUISITION-CORP |
COMPUTE-HEALTH-ACQUISITION-CORP |
62%
|
part of these condensed consolidated financial statements. 6 1. Organization and Basis of Presentation Organization Allurion Technologies, Inc. (“Allurion” or the “Company”) is a vertically integrate… |
| COMPUTE-HEALTH-CORP |
COMPUTE-HEALTH-CORP |
62%
|
part of these condensed consolidated financial statements. 6 1. Organization and Basis of Presentation Organization Allurion Technologies, Inc. (“Allurion” or the “Company”) is a vertically integrate… |
| COMPUTE-HEALTH-LLC |
COMPUTE-HEALTH-LLC |
62%
|
part of these condensed consolidated financial statements. 6 1. Organization and Basis of Presentation Organization Allurion Technologies, Inc. (“Allurion” or the “Company”) is a vertically integrate… |
| DELAWARE-GENERAL-CORPORATION |
DELAWARE-GENERAL-CORPORATION |
62%
|
her Countries 1,712 3,451 Total Revenues $ 2,947 $ 5,580 9 There was no revenue generated in the United States from sales of the Allurion Balloon during each of the three months ended March 31, 2026 … |
| FUNDAMENTAL-CHANGE-COMPANY |
FUNDAMENTAL-CHANGE-COMPANY |
62%
|
FVO election of ASC 825 as the notes contain embedded derivatives, including the conversion upon Stockholder Approval, the conversion upon a Fundamental Change Company Notice, the conversion upon a M… |
| LEAVITT-EQUITY-PARTNERS-LLC |
LEAVITT-EQUITY-PARTNERS-LLC |
62%
|
$ 1.23 Risk-free interest rate 3.5 % 3.5 % Expected term (in years) 2.3 2.6 Expected volatility 145.0 % 145.0 % RTW Convertible Notes The RTW Convertible Notes are accounted for using the FVO electio… |
| PRESENTATION-ORGANIZATION-ALLURION-TECHNOLOGIES- |
PRESENTATION-ORGANIZATION-ALLURION-TECHNOLOGIES- |
62%
|
part of these condensed consolidated financial statements. 6 1. Organization and Basis of Presentation Organization Allurion Technologies, Inc. (“Allurion” or the “Company”) is a vertically integrate… |
